Zediss Healthcare Launches Prameha Moksham

Zediss Healthcare, a Kerala based healthcare company, today launched its effective herbal cure for Diabetes, Prameha Moksham - “An ultimate freedom from Diabetes.” Understanding the growing Diabetic population in the city, Zediss Healthcare in association with the historically known Changampally Vaidya Bhavan has put Prameha Moksham in the limelight.

Prameha Moksham is a promising Diabetic Reversal therapy that has been a prescription treatment to the Diabetic patients of Changampally Vaidya Bhavan. The therapy covers a wider spectrum of healing a Diabetic body, soothing the mind, body and soul. The package includes an herbal medicinal package, diet plan, exercise regimen, etc., that has the knack to take care of the overall health.

This effective cure for Diabetes was launched by Mr.Bassam Mohammed, Founder Chairman, Zediss Group, Further going ahead Dr. Adil Mohammad, Executive Director, Zediss Healthcare Pvt. Ltd. & Dr. Chaithanya KS, Technical Advisor, Zediss Healthcare Pvt. Ltd took the charge to introduce the product launched the Prameha Moksham website that would be helpful for providing all the information about the diabetes cure in an herbal way.

The day also witnessed the launch of an Android Application by Dr. Gibu Gurukkal or Prameha Moksham which is new to Ayurvedic Industy. The application would prove helpful to get any information on the go, related to diabetes cure through Prameha Moksham.

Marking the Indian Independence Day Zediss Healthcare has also associated with 12 authorized centres in Bangalore to provide freedom from diabetes, where Prameha Moksham will be readily available under doctors’ prescription. Few of these centres include; Kailasam Kerala Ayurveda, Vedam Ayurveda Multi Speciality Hospital, Angam Ayurveda, Ayush Therapy Centres, Ayur Sree & many others.

About Zediss Healthcare Pvt. Ltd.
One of the arms of Zediss Group that has focused itself in providing the healthcare solutions to diabetics, the group firmly agrees to the age old saying, ‘Health is Wealth’ and hence, invests in a lot of efforts and perseverance for building a healthier community. Ayurveda being the most traditionally practised treatment, Zediss Healthcare has adopted the Ayurvedic treatment methodologies blended well with the modern day’s diagnostic approach. The firm and its associates are on the move to nurture a health conscious society and its people.

Since inception, Zediss Healthcare has been helping out people suffering from various ailments. The one and only factor that makes Zediss Healthcare stand unique is its keen and holistic approach at an affordable cost. At Zediss healthcare, ‘Reliving Ayurveda’ is the mantra.


About Zediss Group of Companies
Zediss Group is a fast paced Indian conglomerate with a multi-faceted portfolio in Healthcare, Real Estate, Plastics, Herbal Products and Merchandising Industries. The group is determined to design, develop and deliver the products and services to meet beyond customers’ expectations.  They are committed to stay updated according to the current trends and innovative demands of the market. Zediss Group lives on the philosophy of developing different ideas and carving unique strategies to empower the public.

Changampally Vaidya Bhavan
Evolved from Changampally, Gurukkal family has been one of the most renowned Ayurvedic practioners in Malappuram district of Kerala. They are specialized in Asthi Marma Chikitsa and were popular for their expertise in Kalarippayattu. Their origin was from Karnataka and they belonged to Brahmin Tulu family. The great King at that time, called The Zamourins, brought them to Kerala on knowing their expertise in treating the difficult injury and bone fractures. They treated the soldiers had participated in Mamangam. Since then, they dominated in treating with Ayurveda and gained popularity in the North Malabar of Kerala. It is now located in Thirunavaya in Malappuram district.

GRAF eyes South Indian Market; expect 25% sales revenue from the southern states

Gujarat Research Allopathic Foundation Laboratories Pvt. Ltd (GRAF) is all set to expand its operations in the four southern states of India with the launch of its Specialty, Diabetes, Cardiology, Gastroenterology and Orthopedics products in the region. The Pharma division of the Ahmedabad-based entity already promotes Anti-Infectives, Pain management and Nutraceutical products in the state of Karnataka, which turns out to be very important market for the company with contribution of about 25% in the total sales revenue.

"Making inroads into the south Indian pharmaceutical market holds significance for us, since it accounts for about 29% of the overall Indian market. Apart from that, Bangalore, being the IT & BT capital of the country, is one of the fastest growing cities and incidence of some lifestyle diseases like diabetes, hypertension and gastro intestinal disorders is also expected to increase with similar space. In such a scenario, some products offered by GRAF such as Probiflora, the only 7 million spores Probiotic meant for a healthy GI system and the complete range of diabetes and hypertension medicines have a good potential in this market. The company expects that about 25% of the total sales will be generated from the four southern states," said, Mr. Shivender Aggarwal, CEO GRAF.

Having its base in Gujarat and with two state-of-the-art facilities - one in Himachal Pradesh & other one in Ahmedabad, GRAF has emerged as a significant global player in the field of manufacturing and marketing of the branded formulations particularly for various therapeutic segments. Not only in the domestic market, but the Rs. 200-crore entity has left extensive footprint in global markets such as ASEAN, AFRO-MENA ,LATUM countries just within ten years after inception and the wellness division of the company is already charged up for a foray into the US, Canadian, European, Japanese, Korean, Australasian and African marketplaces. While over 1,300 dedicated employees and a robust network of over 1500 distributors are the backbone of the company, prime focus on F&D activity and commitment to quality are its core strength.

GRAF offers a wide range of products for almost all of the therapeutic segments such as anti-infectives, cardio-metabolic, gastroenterology, orthopedics, pain management, diabetology and nutraceuticals. Products offered by its wellness division include nutraceuticals, herbal nutrition, OTC and & other pharmaceuticals products.

Company's plant in Ahmedabad, spread over an area of 25 acres, has a 1,40,000 square feet facility with a dedicated 50,000 square feet cephalosporin unit. Both of the manufacturing units are capable of producing products compliant to internationals standards like WHO, ANVISA, MHRA, EU and USFDA. With plans for expansion afoot, the company is also in the process of getting accreditation from TGA, MCC and USFDA.